Moderna
MRNA
#539
Rank
$36.31 B
Marketcap
$95.06
Share price
3.06%
Change (1 day)
-31.05%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: $36.31 Billion

As of March 2024 Moderna has a market cap of $36.31 Billion. This makes Moderna the world's 539th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Market cap Change
2024$36.31 B-4.22%
2023$37.91 B-45.05%
2022$69.00 B-32.99%
2021$102.97 B149.1%
2020$41.33 B528.01%
2019$6.58 B31.11%
2018$5.02 B

End of Day market cap according to different sources

On Mar 2nd, 2024 the market cap of Moderna was reported to be:

$36.31 Billion
by Yahoo Finance info icon info icon
$36.31 Billion
by CompaniesMarketCap info icon info icon
$36.31 Billion
by Iex Cloud info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$390.50 B 975.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$210.34 B 479.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$321.54 B 785.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$30.13 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.97 B-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.83 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.22 B-47.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.47 B-87.69%๐Ÿ‡บ๐Ÿ‡ธ USA